BGPT: Author Review: Erik Rasmussen

Explore by Goal

Quick Explanation Copied

Erik Rasmussen (as provided): the available evidence in your prompt is insufficient and likely name-ambiguous to support a rigorous “scientific strength” assessment.

Long Explanation

Author Review: Erik Rasmussen

Evidence basis: only the data you provided in the prompt (metrics + two listed works + OpenAlex matches summary). No additional paper metadata/full-text was provided here.

1) Evidence inventory (what we actually have)

Prompt-provided Erik Rasmussen metrics: “h-index of 0, total citations of 0, paper count of 2” and two works listed: “Framställning av fusidsyratabletter” and a book “Leif Lewin, Ideologi och strategi…”.
Prompt-provided OpenAlex matches: multiple “Erik Rasmussen” variants exist (name ambiguity). One match explicitly shows works_count=175, cited_by_count=6763, h_index=37.
Critical issue: your prompt also includes a different “Todd E. Rasmussen” with far higher metrics (h-index 60, cited_by_count 16786). This demonstrates the real risk of conflating different people who share similar names.

Skeptical constraint: Because only titles + partial metrics are provided (not DOIs, abstracts, methods, or study outcomes), a strict scientific-strength evaluation (rigor, reproducibility, contribution) cannot be substantiated.

2) Disambiguation red-flags (highest priority)

Name collisions are not hypothetical: your OpenAlex “matches” list contains many “Erik Rasmussen” variants and also “Todd E. Rasmussen”. Without ORCID, affiliation, and paper-level identity checks, any attempt to judge “Erik Rasmussen” scientifically risks evaluating the wrong individual.

What would change the conclusion? If the two “Erik Rasmussen” works you provided are not the same author as the one with h-index 37 (OpenAlex match), then the scientific strength estimate must be treated as unknown rather than “low”. Conversely, if they are the same person and the works are indeed the only outputs, then scientific impact would likely be limited by publication volume and/or venue indexing.

3) Citation-metric visualization (from your provided numbers)

Note: the metrics shown are taken only from your prompt text; they are not verified against an external identifier here.

Interpretation (careful): Citation metrics are not direct measures of biological rigor; they are also confounded by field size, indexing coverage, career length, co-authorship patterns, and name disambiguation errors.

4) Scientific-strength assessment (what can/can’t be concluded)

4.1 What is known from your prompt

Your prompt lists two works for “E. Rasmussen”: one Swedish-titled work about fusidic acid tablets and one book review/entry about ideology and strategy in Swedish politics.
A politics/ideology book entry is not automatically biological/medical science evidence; it may indicate non-biological scholarly activity or simply miscitation/metadata mismatch.

4.2 What is unknown

Whether the fusidic-acid-related work is a peer-reviewed biomedical study, a formulation/process patent, or a local-language technical report.
Study design, sample size, methods, controls, reproducibility, and whether results are statistically and mechanistically supported.
Any additional biological contributions beyond those two listed titles.

Therefore: A rigorous, evidence-based “scientific strength” score for “Erik Rasmussen” is not supportable from the current prompt evidence. The correct scientific posture here is to label the uncertainty as high until author identity and paper-level methods/outcomes are verified.

5) Practical next steps to make this review scientifically valid

Lock identity: capture ORCID (if any) and list the exact works attributed to that ORCID.
Extract methods/outcomes: for each top work, record design type (in vitro/in vivo/clinical), endpoints, controls, statistical analysis, and effect sizes.
Assess rigor: check blinding/randomization (if applicable), batch effects, preregistration (if applicable), and whether datasets/code are available.
Assess robustness: look for replication, independent cohorts, consistency across studies, and publication-quality signals (journal/venue indexing, not prestige).

Bottom line (scientific posture): With the current evidence, the safest scientifically-rigorous classification is “insufficient evidence / likely name ambiguity”, so any strong statement about scientific strength would be guesswork.

Feedback:

Updated: April 20, 2026